Prevention of type 1 diabetes in the rat with an allele-specific anti-t-cell receptor antibody: Vβ13as a therapeutic target and biomarker

Diabetes

Volumn 61, Issue 5, 2012, Pages 1160-1168

  Liu, Zhijun ^a,e   Cort, Laura ^b   Eberwine, Ryan ^b   Herrmann, Thomas ^c   Leif, Jean H ^a   Greiner, Dale L ^a   Yahalom, Barak ^d   Blankenhorn, Elizabeth P ^b   Mordes, John P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d Biomedical Research Models Inc   (United States)

^e WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; MONOCLONAL ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN V BETA 13A; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HISTOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ALLELES; ANIMALS; ANTIBODIES, MONOCLONAL; DIABETES MELLITUS, TYPE 1; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; ISLETS OF LANGERHANS; MALE; POLY I-C; RATS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 84860579280     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0867     Document Type: Article

References (41)

1. Morran MP, Omenn GS, Pietropaolo M. Immunology and genetics of type 1 diabetes. Mt Sinai J Med 2008;75:314-327
2. Keymeulen B, Walter M, Mathieu C, et al. Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia 2010;53:614-623
3. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, et al.; Type 1 Diabetes TrialNet Anti-CD20 Study Group. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009;361:2143-2152
4. Stadinski BD, Zhang L, Crawford F, Marrack P, Eisenbarth GS, Kappler JW. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc Natl Acad Sci USA 2010;107:10978-10983
5. Mordes JP, Poussier P, Rossini AA, Blankenhorn EP, Greiner DL. Rat models of type 1 diabetes: genetics, environment, and autoimmunity. In Animal Models of Diabetes: Frontiers in Research. 2nd ed. Shafrir E, Ed. Boca Raton, FL, CRC Press, 2007, p. 1-39
6. Ellerman KE, Like AA. Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats. Diabetologia 2000;43:890-898 (Pubitemid 30463169)
7. Awata T, Guberski DL, Like AA. Genetics of the BB rat: association of autoimmune disorders (diabetes, insulitis, and thyroiditis) with lymphopenia and major histocompatibility complex class II. Endocrinology 1995;136:5731-5735
8. Martin A-M, Maxson MN, Leif J, Mordes JP, Greiner DL, Blankenhorn EP. Diabetes-prone and diabetes-resistant BB rats share a common major diabetes susceptibility locus, iddm4: additional evidence for a "universal autoimmunity locus" on rat chromosome 4. Diabetes 1999;48:2138-2144 (Pubitemid 29521842)
9. Blankenhorn EP, Rodemich L, Martin-Fernandez C, Leif J, Greiner DL, Mordes JP. The rat diabetes susceptibility locus Iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection. Diabetes 2005;54:1233-1237 (Pubitemid 40446342)
10. Mordes JP, Cort L, Norowski E, et al. Analysis of the rat Iddm14 diabetes susceptibility locus in multiple rat strains: identification of a susceptibility haplotype in the Tcrb-V locus. Mamm Genome 2009;20:162-169
11. Mordes JP, Leif J, Novak S, DeScipio C, Greiner DL, Blankenhorn EP. The iddm4 locus segregates with diabetes susceptibility in congenic WF. iddm4 rats. Diabetes 2002;51:3254-3262 (Pubitemid 35246972)
12. Hornum L, DeScipio C, Markholst H, et al. Comparative mapping of rat Iddm4 to segments on HSA7 and MMU6. Mamm Genome 2004;15:53-61 (Pubitemid 38096210)
13. Blankenhorn EP, Descipio C, Rodemich L, et al. Refinement of the Iddm4 diabetes susceptibility locus reveals TCRVbeta4 as a candidate gene. Ann NY Acad Sci 2007;1103:128-131 (Pubitemid 46791120)
14. Fuller JM, Bogdani M, Tupling TD, et al. Genetic dissection reveals diabetes loci proximal to the gimap5 lymphopenia gene. Physiol Genomics 2009;38:89-97
15. Stienekemeier M, Hofmann K, Gold R, Herrmann T. A polymorphism of the rat T-cell receptor beta-chain variable gene 13 (BV13S1) correlates with the frequency of BV13S1-positive CD4 cells. Immunogenetics 2000;51:296-305 (Pubitemid 30198884)
16. Mordes JP, Guberski DL, Leif JH, et al. LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation. Diabetes 2005;54:2727-2733 (Pubitemid 41233596)
17. Tirabassi RS, Guberski DL, Blankenhorn EP, et al. Infection with viruses from several families triggers autoimmune diabetes in LEW*1WR1 rats: prevention of diabetes by maternal immunization. Diabetes 2010;59:110-118
18. Institute of Laboratory Animal Resources. Commission on Life Sciences, National Research Council: Guide for the Care and Use of Laboratory Animals. Washington, DC, National Academy Press, 1996
19. Kampinga J, Kroese FG, Pol GH, et al. A monoclonal antibody to a determinant of the rat T cell antigen receptor expressed by a minor subset of T cells. Int Immunol 1989;1:289-295 (Pubitemid 19263687)
20. Jarchum I, Takaki T, DiLorenzo TP. Efficient culture of CD8(+) T cells from the islets of NOD mice and their use for the study of autoreactive specificities. J Immunol Methods 2008;339:66-73
21. Parker DC, Greiner DL, Phillips NE, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 1995;92:9560-9564
22. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967;16:35-39
23. Bewick V, Cheek L, Ball J. Statistics review 12: survival analysis. Crit Care 2004;8:389-394 (Pubitemid 39468062)
24. Arndt T, Wedekind D, Weiss H, et al. Prevention of spontaneous immune-mediated diabetes development in the LEW.1AR1-iddm rat by selective CD8+ T cell transfer is associated with a cytokine shift in the pancreas-draining lymph nodes. Diabetologia 2009;52:1381-1390
25. Métroz-Dayer M-D, Mouland A, Brideau C, Duhamel D, Poussier P. Adoptive transfer of diabetes in BB rats induced by CD4 T lymphocytes. Diabetes 1990;39:928-932 (Pubitemid 20233726)
26. Sethi DK, Schubert DA, Anders AK, et al. A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC. J Exp Med 2011;208:91-102
27. Gras S, Chen Z, Miles JJ, et al. Allelic polymorphism in the T cell receptor and its impact on immune responses. J Exp Med 2010;207:1555-1567
28. Burrows SR, Chen Z, Archbold JK, et al. Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Proc Natl Acad Sci USA 2010;107:10608-10613
29. Quinn A, McInerney M, Huffman D, et al. T cells to a dominant epitope of GAD65 express a public CDR3 motif. Int Immunol 2006;18:967-979 (Pubitemid 43983292)
30. Haskins K. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv Immunol 2005;87:123-162 (Pubitemid 41133493)
31. Shizuru JA, Taylor-Edwards C, Livingstone A, Fathman CG. Genetic dissection of T cell receptor V β gene requirements for spontaneous murine diabetes. J Exp Med 1991;174:633-638
32. + T cells expressing identical endogenous TCR-α chains. J Immunol 1996;157:4726-4735
33. Dudek NL, Thomas HE, Mariana L, et al. Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy β-cells via the perforin and Fas pathways. Diabetes 2006;55:2412-2418 (Pubitemid 44871141)
34. Drexler K, Burtles S, Hurtenbach U. Limited heterogeneity of T-cell receptor V β gene expression in the early stage of insulitis in NOD mice. Immunol Lett 1993;37:187-196 (Pubitemid 23303734)
35. Baker FJ, Lee M, Chien YH, Davis MM. Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice. Proc Natl Acad Sci USA 2002;99:9374-9379 (Pubitemid 34764621)
36. Galley KA, Danska JS. Peri-islet infiltrates of young non-obese diabetic mice display restricted TCR β-chain diversity. J Immunol 1995;154:2969-2982
37. Abiru N, Wegmann D, Kawasaki E, Gottlieb P, Simone E, Eisenbarth GS. Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse. J Autoimmun 2000;14:231-237
38. Li L, He Q, Garland A, et al. Beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct. J Immunol 2009;183: 7585-7591
39. β 8 T-lymphocyte-receptor monoclonal antibody therapy in NOD/Wehi mice. Diabetes 1989;38:1492-1495
40. β 8 antibody therapy prevents disease recurrence in fetal pancreas isografts in spontaneously diabetic nonobese diabetic mice. Transplant Proc 1992;24:220-221
41. Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 1999;5:601-604 (Pubitemid 29289413)